A Randomized Controlled Trial Testing Provision of Fecal and Blood Test Options on Participation for Colorectal Cancer ScreeningErin L. Symonds, Graeme P. Young, Robert Fraser et al.|Cancer Prevention Research|2019Cited by 23
“Rescue” of Nonparticipants in Colorectal Cancer Screening: A Randomized Controlled Trial of Three Noninvasive Test OptionsGraeme P. Young, Erin L. Symonds, Ellen McGrane et al.|Cancer Prevention Research|2021Cited by 20
Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in <i>BCAT1</i> and <i>IKZF1</i>Susanne K. Pedersen, Graeme P. Young, Naima Loayza et al.|Cancer|2022Cited by 19
Comparing a fecal immunochemical test and circulating tumor DNA blood test for colorectal cancer screening adherenceGeraldine Laven‐Law, Graeme P. Young, Jean M. Winter et al.|Journal of Gastroenterology and Hepatology|2024Cited by 4